Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides

Histochemical Journal

Volumn 28, Issue 10, 1996, Pages 681-687

  Haltia, Anni ^a   Solin, Marja Liisa ^a   Jalanko, Hannu ^b   Holmberg, Christer ^b   Miettinen, Aaro ^a   Holthöfer, Harry ^a  

^a Dept of Bacteriology and Immunology ^*  (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GLYCOSPHINGOLIPID; MESSENGER RNA; PROSAPOSIN; SPHINGOLIPID ACTIVATOR PROTEIN;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYSOSOME STORAGE DISEASE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029822875     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02409005     Document Type: Article

References (37)

1. BREMER, E.G., SCHLESSINGER, J. & HAKOMORI, S.-I. (1986) Ganglioside mediated modulation of cell growth. J. Biol. Chem. 261, 2434-40.
2. CHERESH, D.A., VARKI, A.J., VARKI, N.M., STALLCUP, W.B., LEWINE, J. & REISFELD, R.A. (1984) A monoclonal antibody recognizes an O-acetylated sialic acid in a human melanoma-associated ganglioside. J. Biol. Chem. 259, 7453-9.
3. CHERESH, D.A., PIERSCHBACHER, M.D., HERZIG, M.A. & MUJOO, K. (1986) Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J. Cell Biol. 102, 688-96.
4. CHIRGWIN, J.M., PRZYBYLA, A.E., MacDONALD, R.J. & RUTTER, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-9.
5. CONZELMANN, E. & SANDHOFF, K. (1978) AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Proc. Natl. Acad. Sci. USA 75, 3979-83.
6. FINGERHUT, R., VAN DER HORST, G., VERHEIJEN, F.W. & CONZELMANN, E. (1992) Degradation of gangliosides by the lysosomal sialidase requires an activator protein. J. Biochem. 208, 623-9.
7. FISHMAN, P.H. & BRADY, R.O. (1976) Biosynthesis and function of gangliosides. Science 194, 906-15.
8. FÜRST, W. & SANDHOFF, K. (1992) Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim. Biophys. Acta 1126, 1-16.
9. HALLMAN, N., HJELT, L. & AHVENAINEN, E.K. (1956) Nephrotic syndrome in newborn and young infants. Ann. Pediatr. Fenn. 2, 227-41.
10. HIRAIWA, M., SOEDA, S., KISHIMOTO, Y. & O'BRIEN, J.S. (1992) Binding and transport of gangliosides by prosaposin. Proc. Natl. Acad. Sci. USA 89, 11254-8.
11. HOLMBERG, C., ANTIKAINEN, M., RÖNNHOLM, K., ALAHOUHALA, M. & JALANKO, H. (1995) Management of the congenital nephrotic syndrome of the Finnish type. Pediatr. Nephrol. 9, 87-93.
12. HOLTHÖFER, H., REIVINEN, J. & MIETTINEN, A. (1990) Acidic glycolipids in human glomeruli. Evidence of specific changes in congenital nephrosis of the Finnish type. J. Am. Soc. Nephrol. (abstract) 1.
13. HSIAO, K. (1991) A fast and simple procedure for sequencing double stranded DNA with sequenase. Nucl. Add. Res. 19, 2787.
14. INUI, K., EMMETT, M. & WENGER, D.A. (1983) Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy. Proc. Natl. Acad. Sci. USA 80, 3074-7.
15. KISHIMOTO, Y., HIRAIWA, M. & O'BRIEN, J.S. (1992) Saposins: structure, function, distribution, and molecular genetics. J. Lipid Res. 33, 1255-67.
16. KOJIMA, N. & HAKOMORI, S.-I. (1989) Specific interaction between triaosylceramide (Cg3) and sialosyllactosyl-ceramide (GM3) as a basis for specific cellular recognition between lymphoma and melanoma cells. J. Biol. Chem. 264, 20159-62.
17. KRETZ, K.A., CARSON, G.S., MORIMOTO, S., KISHIMOTO, Y., FLUHARTY, A.L. & O'BRIEN, J.S. (1990) Characterization of a mutation in a family with saposin B deficiency: A glycosylation site defect. Proc. Natl. Acad. Sci. USA 87, 2541-4.
18. KRUG, M.S. & BERGER, S.L. (1987) First strand cDNA synthesis primed with oligo(dT). In Methods in Enzymology (edited by BERGER, S.L & KIMMEL, A.R.) pp. 316-25. San Diego: Academic Press.
19. LAEMMLI, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-5.
20. LI, S.-C., SONNINO, S., TETTAMANTI, G. & LI, Y.-T. (1988) Characterization of nonspecific activator protein for the enzymatic hydrolysis of glycolipids. J. Biol. Chem. 263, 6588-91.
21. MIETTINEN, A., DEKAN, G. & FARQUHAR, M.G. (1990) Monoclonal antibodies against membrane proteins of rat glomerulus. Am. J. Pathol. 137, 929-44.
22. MORIMOTO, S., YAMAMOTO, Y., O'BRIEN, J.S. & KISHIMOTO, Y. (1990) Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases. Proc. Natl. Acad. Sci. USA 87, 3493-7.
23. NOJIRI, H., TAKAKU, F., TERUI, Y., MIURA, Y. & SAITO, M. (1986) Ganglioside GM3: An acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U 937. Proc. Natl. Acad. Sci. USA 83, 782-6.
24. O'BRIEN, J.S. & KISHIMOTO, Y. (1991) Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J. 5, 301-8.
25. SAMBROOK, J., FRITSCH, E.F. & MANIATIS, T. (1989) Molecular cloning. A Laboratory Manual. 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
26. SANGER, F., NICKLEN, S. & COULSON, A.R. (1977) DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-7.
27. SANO, A., HINENO, T., MIZUNO, T., KONDOH, K., UENO, S.-I., KAKIMOTO, Y. & INUI, K. (1989) Sphingolipid hydrolase activator proteins and their precursors. Biochem. Biophys. Res. Commun. 165, 1191-7.
28. SCHNABEL, D., SCHRÖDER, M. & SANDHOFF, K. (1991) Mutation in the sphingolipid activator protein 2 in a patient with a variant form of Gaucher disease. FEBS Lett. 284, 57-9.
29. SCHNABEL, D., SCHRÖDER, M., FÜRST, W., KLEIN, A., HURWITZ, R., ZENK, T., WEBER, J., HARZER, K., PATON, B.C., POULOS, A., SUZUKI, K. & SANDHOFF, K. (1992) Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J. Biol. Chem. 267, 3312-5.
30. SHAYMAN, J.A. & RADIN, N.S. (1991) Structure and function of renal glycosphingolipids. Arn. J. Physiol. 260, F291-302.
31. TAMARU, T., FUJIBAYASHI, S., BROWN, W.R. & WENGER, D.A. (1985) Immunocytochemical localization of sphingolipid activator protein-1, the sulfatide/GM1 ganglioside activator, to lysosomes in human liver and colon. Histochemistry 86, 195-200.
32. VACCARO, A.M., CIAFFONI, F., TATTI, M., SALVIOLI, R., BARCA, A., TOGNOZZI, D. & SCERCH, C. (1995) pH-dependent conformational properties of saposins and their interactions with phospholipid membranes. J. Biol. Chem. 270, 30576-80.
33. VAN ECHTEN, G. & SANDHOFF, K. (1993) Ganglioside metabolism. Enzymology, topology, and regulation. J. Biol. Chem. 268, 5341-4.
34. VARKI, A., HOOSHMAND, F., DIAZ, S., VARKI, N. & HEDRICK, S.M. (1991) Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetylesterase. Cell 65, 65-74.
35. M1 activator protein deficiency. Am. J. Med. Genet. 33, 255-65.
36. WHITEHEAD, T.P., THORPE, G.H.G., CARTER, T.J.N., GROUCUTT, C. & KRICKA, L.J. (1983) Enhanced luminescence procedure for sensitive determination of peroxidase labelled conjugates in immunoassay. Nature 305, 158-9.
37. ZHANG, X.-L., RAFI, M.A., DEGALA, G. & WENGER, D.A (1990) Insertion in the mRNA of metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency. Proc. Natl. Acad. Sci. USA 87, 1426-30.